胃癌术前风险分层:基于双能CT影像组学在两家中心前瞻性数据集的建立
这项前瞻性双中心研究纳入503例胃腺癌患者,从多期双能CT的多色/单色(40 keV、100 keV)/碘图中提取影像组学特征,建立模型识别浆膜侵犯(pT4a)、淋巴结转移(LNM)、脉管侵犯(LVI)和神经侵犯(PNI)。验证集中双能CT模型对上述四项的AUC分别为0.891、0.817、0.834、0.889,与常规增强CT模型相似;训练集中双能CT模型对pT4a、LNM、LVI的识别性能优于常规增强CT模型(均P<0.05),且与无病生存相关(均P<0.05)。
要点
- 双能CT影像组学模型在验证集识别pT4a、LNM、LVI、PNI的AUC为0.891、0.817、0.834、0.889。
- 训练集中双能CT模型对pT4a、LNM、LVI的识别性能优于常规增强CT模型(均P<0.05)。
- 双能CT模型与患者无病生存相关(训练集均P<0.05),可术前分层高危病理表型。
核心结论
- 双能CT影像组学可术前根据胃癌高危病理表型对患者进行分层,并在训练集中与患者无病生存相关。
研究设计与样本
- 前瞻性双中心研究,共招募503例经组织学确诊的胃腺癌患者,训练集396例(60.1±10.8岁,女110例、男286例),验证集107例(61.4±9.5岁,女29例、男78例);患者于2021年1月至2023年7月间在胃切除术前接受三期增强双能CT检查。
诊断标准与关键数值
- 双能CT模型在验证集中识别pT4a、LNM、LVI、PNI的AUC分别为0.891、0.817、0.834、0.889,与常规增强CT模型相似。
临床应用与阅片要点
- 训练集中双能CT模型识别pT4a、LNM、LVI的性能较常规增强CT模型提高(均P<0.05),分层PNI的性能相似(P=0.104)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate the performance of dual-energy CT (DECT)-based radiomics models for identifying high-risk histopathologic phenotypes-serosal invasion (pT4a), lymph node metastasis (LNM), lymphovascular invasion (LVI) and perineural invasion (PNI) in gastric cancer.
MATERIAL AND METHODS: This prospective bi-center study recruited histologically confirmed gastric adenocarcinoma patients who underwent triple-phase enhanced DECT before gastrectomy between January 2021 and July 2023. Radiomics features were extracted from polychromatic/monochromatic (40 keV, 100 keV)/iodine images at arterial/venous/delay phase, respectively. Predictive features were selected in the training dataset using logistic regression classifier, and trained models were applied to the external validation dataset. Performances of clinical models, conventional contrast enhanced CT (CECT) models and DECT models were evaluated using areas under the receiver operating characteristic curve (AUCs).
RESULTS: In total, 503 patients were recruited: 396 at training dataset (60.1 ± 10.8 years, 110 females, 286 males) and 107 at validation dataset (61.4 ± 9.5 years, 29 females, 78 males). DECT models dichotomizing pT4a, LNM, LVI, and PNI achieved AUCs of 0.891, 0.817, 0.834, and 0.889, respectively, in the validation dataset, similar with the CECT models. In the training dataset, compared to the CECT model, the DECT model provided increased performance for identifying pT4a, LNM, LVI (all P<0.05), and similar performance for stratifying PNI (P = 0.104). The DECT models was associated with patient disease-free survival (all P<0.05).
CONCLUSION: DECT radiomics can stratify patients preoperatively according to high-risk histopathologic phenotypes for gastric cancer and are associated with patient disease-free survival in the training dataset.
引用
- Li J, Yin H, Zhang H, et al. Preoperative Risk Stratification for Gastric Cancer: The Establishment of Dual-Energy CT-Based Radiomics Using Prospective Datasets at Two Centers. Acad Radiol. 2024. PMID: 38734580. doi:10.1016/j.acra.2024.04.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。